Indonesia vs Syria: Cause of death, by non-communicable diseases, ages 0-4, male
Indonesia
32.6%
in 2021
Syria
33.1%
in 2021
Indonesia rank
85th
Syria rank
82nd
Cause of death, by non-communicable diseases, ages 0-4, male over time
- Indonesia
- Syria
How they compare
Syria currently reports 33.1% against 32.6% in Indonesia, a difference of 0.5%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Syria ahead.
Indonesia ranks 85th and Syria ranks 82nd of 185 countries.
Syria has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Indonesia | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 12.0% | 29.7% | 17.7% | Syria |
| 2010s | 24.3% | 30.4% | 6.1% | Syria |
| 2020s | 32.3% | 33.3% | 1.0% | Syria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, male, Indonesia or Syria?
- Syria, at 33.1% against 32.6% in Indonesia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, male between Indonesia and Syria?
- 0.5%, with Syria ahead.
- How many years of comparable data are there for Indonesia and Syria?
- 6 years are reported by both, from 2000 to 2021.
- How do Indonesia and Syria rank globally for cause of death, by non-communicable diseases, ages 0-4, male?
- Indonesia ranks 85th and Syria ranks 82nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.